Biomarkers of acute kidney injury

Acute kidney injury (AKI) is a common condition with a high risk of death. The standard metrics used to define and monitor the progression of AKI, ...

Biomarkers of acute kidney injury: From discovery to the future of ...

This review strives to provide a brief historical perspective on AKI, elucidate recent developments in diagnosing and managing AKI, and show the current usage ...

Recommendations on Acute Kidney Injury Biomarkers From the ...

A 23-expert panel developed 11 recommendations for the use of new stress, functional, and damage biomarkers in clinical practice to prevent and manage acute ...

Biomarkers in acute kidney injury | Annals of Intensive Care | Full Text

Acute kidney injury (AKI) is a multifactorial syndrome with a high risk of short- and long-term complications as well as increased health ...

Novel Biomarkers of Kidney Function Introduction and Overview

The researchers concluded that plasma NGAL may serve as a good predictor of AKI in cases of adult poisoning. Notably, though plasma NGAL may ...

Biomarkers in Acute Kidney Injury - PMC

Numerous biomarkers have been used for early detection of AKI but failed to elicit troponin-like performance.

Are biomarkers in acute kidney injury ready for prime time? The time ...

Urine interleukin 18 and lipocalin 2 are biomarkers of acute tubular necrosis in patients with cirrhosis: a systematic review and meta-analysis

Acute Kidney Injury: Biomarker-Guided Diagnosis and Management

Here, we provide a comprehensive review of biomarker-based AKI diagnosis and management and highlight recent developments.

Advances in the study of subclinical AKI biomarkers - Frontiers

This study discusses some of the most promising novel biomarkers of AKI, including CysC, NGAL, KIM-1, lL-18, L-FABP, IGFBP7, TIMP-2, Clusterin, and Penkid.

Review of the limitations of current biomarkers in acute kidney injury ...

Studies have indicated disadvantages and limitations with the current acute kidney injury biomarkers, including lack of sensitivity and specificity.

Biomarker-Based Management of AKI: Fact or Fantasy? | Nephron

In this review, we summarize the current role of new AKI biomarkers in the management of AKI and outline some of the ongoing limitations and challenges.

Investigational biomarkers and the evaluation of acute kidney injury

Outline · Soluble urokinase plasminogen activator receptor (suPAR) · Dickkopf-3 · Uromodulin (Tamm-Horsfall protein) · Plasma NGAL · Urinary ...

Biomarkers in acute kidney injury: On the cusp of a new era? - JCI

A framework that incorporates testing for urinary CXCL9 may improve the accuracy of diagnosis and management of AKI. Clinicians rely on kidney ...

Biomarkers and predicting acute kidney injury - Wiley Online Library

Are there faster and better tests that reflect decreased renal function and increased acute kidney injury (AKI) risk?

Exploring the Landscape of Biomarkers in Acute Kidney Injury - MDPI

In this review, we propose an up-to-date and comprehensive summary of advancements that identified novel biomarker candidates in blood and urine.

Utility of Biomarkers for Sepsis-Associated Acute Kidney Injury Staging

The findings suggest that assessment of the cell-cycle arrest biomarkers TIMP-2 and IGFBP7 may augment AKI staging for patients with functional criteria for ...

Meeting Report Potential use of biomarkers in acute kidney injury

This article provides a summary of the key findings and recommendations of the group, to equip clinicians to effectively use biomarkers in AKI.

Biomarkers of Acute Kidney Injury - Annual Reviews

Acute kidney injury (AKI) is a common condition with a high risk of death. The standard metrics used to define and monitor the progression ...

Biomarkers of AKI: A Review of Mechanistic Relevance and Pot...

This review highlights the major studies that have characterized the diagnostic and prognostic predictive power of these biomarkers.

Biomarkers of acute kidney injury: the pathway from discovery to ...

Several new AKI biomarkers have been discovered and validated to improve early detection, differential diagnosis, and differentiation of patients into risk ...